Tag: Cancer: Misc.
December 2018 Briefing – Hematology & Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for December 2018. This roundup includes...
Proportion of Cancers Due to Excess Body Weight Varies by State
Population-attributable fraction varied from 3.9 percent in Montana to 6.0 percent in Texas for men
New Guidelines Address Care for Malignant Pleural Effusions
Recs call for ultrasounds, advise against therapeutic pleural interventions in asymptomatic patients
Risk of Arterial Thromboembolic Events Up Prior to Cancer Diagnosis
In seniors, risk of arterial thromboembolic events peaked in the 30 days immediately before diagnosis
Sorafenib for Desmoid Tumors Ups Progression-Free Survival
Two-year progression-free survival rate 81 percent with sorafenib vs. 36 percent with placebo
Exercise Linked to Reduced Mortality for Patients With Cancer
Mortality rate lower for habitually active patients and for those who started exercising after diagnosis
Risk for Zoster Up Before Dx, During Tx of Hematologic Cancer
For solid organ cancers, the risk is greater among those receiving chemotherapy
Apixaban Prevents VTE in Cancer Patients Initiating Chemotherapy
Major bleeding occurred in more apixaban-treated than control patients
November 2018 Briefing – Hematology & Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for November 2018. This roundup includes...
Teva Recalls Two Blood Pressure Medications
Tablets tainted with N-nitrosodiethylamine, a suspected human carcinogen
